RT MicroDx is reshaping the healthcare landscape by developing accurate, affordable, at-home molecular testing solutions that empower individuals, alleviate financial distress, and contribute to healthier communities worldwide. Our readerless RT LAMP reaction, utilizing saliva samples, empowers individuals and families to take control of their health journey from the comfort of their homes. 
 
Leveraging our scalable testing platform, we are currently developing the first over-the-counter, molecular-based, at-home test for strep, the “RST,” offering a simplistic yet robust and inexpensive testing solution that only requires a saliva sample rather than a painful and invasive throat swab. With accuracy levels reaching 97% specificity and 99% sensitivity, our solutions transcend traditional at-home testing barriers, offering timely and reliable results.


Health Care

Health Diagnostics

Medical Devices

mHealth

RT MicroDx

RT MicroDx's headquarters in Boston, United States

Description

People (2)

Nathalya Mamane

Prosper Wiredu Ackah

Jobs